Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: The experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature

Haemophilia

Volumn 13, Issue 6, 2007, Pages 685-696

  Asatiani, Ekatherine ^a   Kessler, C M ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Haemophilia; Qualitative platelet defects; Thrombasthenias; Von Willebrand's disease

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RISTOCETIN;

ADENOIDECTOMY; ADULT; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN HEMORRHAGE; CHILD; CIRCUMCISION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD CLOTTING DISORDER; CONTROLLED STUDY; CRYOPRECIPITATION; DRUG HALF LIFE; DYSPHAGIA; DYSPNEA; EHLERS DANLOS SYNDROME; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH CENTER; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HETEROZYGOTE; HUMAN; INFANT; LASER SURGERY; MALE; MUCOSAL BLEEDING; MUSCLE HEMATOMA; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UNITED STATES; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; COAGULANTS; FACTOR VIII; FEMALE; HEMOPHILIA B; HUMANS; INFANT; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS; THROMBASTHENIA; TREATMENT OUTCOME; UNITED STATES; VON WILLEBRAND DISEASE;

EID: 35548970202     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01541.x     Document Type: Review

References (35)

1. Von Willebrand EA. Hereditary pseudohaemophilia. Haemophilia 1999; 5: 223-31.
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
3. Bowie EJ. Von Willebrand's disease. Clinical picture, diagnosis, and treatment. Clin Lab Med 1984; 4: 303-17.
4. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffmann T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest 1989; 83: 288-97.
5. Koedam JA, Meijers JC, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-43.
6. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. von Willebrand's disease in the year 2003: Towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003; 88: 94-108.
7. Keeney S, Cumming AM. The molecular biology of von Willebrand disease. Clinic Lab Haematol 2001; 23: 209-30.
8. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
9. Casonato A, Pontara E, Sartorello F, Gemmati D, Cattini MG, Girolami A. Combined hemophilia A and type 2 von Willebrand's disease: Defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. Haematologica 2001; 86: 1110-1.
10. Casonato A, Pontara E, Boscaro M, Dannhauser D, Sartori MT, Girolami A. Combined haemophilia A and type I von Willebrand's disease: A family study including an evaluation of the effects of DDAVP infusion. Haematologia (Budap) 1993; 25: 57-67.
11. Miller CH, Hilgartner MW, Harris MB, Bussel JB, Aledort LM. Concurrence of von Willebrand's disease and hemophilia A: Implications for carrier detection and prevalence. Am J Med Genet 1986; 24: 83-94.
12. Linares Ruiz MS, Rodriguez Fernandez JM. Association of von Willebrand's disease and factor IX deficiency in males and females of a family. Sangre (Barc) 1983; 28: 782-91.
13. Pernod G, Vinciguerra C, Gaucher C, Mazurier C, Polack B, Negrier C. Combined hereditary disorders of haemophilia B Leyden (-6 G->A) and type 1 von Willebrand disease. Thromb Haemost 1996; 76: 151-5.
14. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153-8.
15. Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978; 51: 1223-8.
16. Chediak J, Lambert E, Johnson EI, Telfer MC. Combined severe factor XI deficiency and von Willebrand's disease. Am J Clin Pathol 1980; 74: 108-14.
17. Perrys S, Opfell R, Baker M. Combined deficiencies of PTA and AHG. Blood 1960; 16: 1184-98.
18. Gordon S, Hewitt B, Raik E. Combined factor XI and factor VIII deficiency in one family. Sixteenth Congress of International Society on Hematology, 1975; Proceedings.
19. Sano M, Saito H, Shimamoto Y, et al. Combined hereditary factor XI (plasma thromboplastin antecedent) deficiency, von Willebrand's disease, and xeroderma pigmentosum in a Japanese family. Am J Hematol 1993; 44: 129-33.
20. Tavori S, Brenner B, Tatarsky I. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis. Thromb Haemost 1990; 63: 36-8.
21. Lian EC, Deykin D, Harkness DR. Combined deficiencies of Factor VIII (AHF) and Factor XI (PTA). Am J Hematol 1976; 1: 319-24.
22. Brenner B, Laor A, Lupo H, Zivelin A, Lanir N, Seligsohn U. Bleeding predictors in factor XI-deficient patients. Blood Coagul Fibrinolysis 1997; 8: 511-5.
23. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE. FXII. Blut 1990; 61: 258-66.
24. Schloesser M, Zeerleder S, Lutze G, et al. Mutations in the human factor XII gene. Blood 1997; 90: 3967-77.
25. Lammle B, Wuillemin WA, Huber I, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency - a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991; 65: 117-21.
26. Nitu-Whalley IC, Hermans C, Lee CA. Prevalence of clotting factor deficiencies in a large population with von Willebrand disease. Thromb Haemost 2000; 84: 514-5.
27. Barthels M, Edel J, Liese B, Karges HE. Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome. Klin Wochenschr 1982; 60: 303-9.
28. Zeitler P, Meissner N, Kreth HW. Combination of von Willebrand disease type 1 and partial factor XII deficiency in children: Clinical evidence for a diminished bleeding tendency. Acta Paediatr 1999; 88: 1233-7.
29. Mariani G, Herrmann FH, Bernardi F, Schved JF, Auerswald G, Ingerslev J. Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: The International Registry on Congenital Factor VII Deficiency (IRF7). Blood 2000; 96: 374.
30. Girolami A, Pontara E, Dannhauser D, et al. First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. Blood Coagul Fibrinolysis 1993; 4: 177-81.
31. Lychev VG, Tsiguleva OA, Bishevskii KM, Tarasova NI, Merzliakova NV. Congenital deficiency of factor VII in combination with Willebrand's syndrome. Ter Arkh 1982; 54: 119-21.
32. White B, O'Connor H, Smith OP. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency. Blood Coagul Fibrinolysis 2000; 11: 155-7.
33. Wong WY, Huang WC, Miller R, McGinty K, Whisnant JK. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 2000; 6: 50-4.
34. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 1999; 5: 253-9.
35. White B, Martin M, Kelleher S, Browne P, McCann SR, Smith OP. Successful use of recombinant FVIIa (Novoseven) in the management of pulmonary haemorrhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency. Br J Haematol 1999; 106: 254-5.